Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000760799 | SCV000890694 | pathogenic | not provided | 2018-10-08 | criteria provided, single submitter | clinical testing | The E148X variant in the TBC1D24 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The E148X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret E148X as a pathogenic variant. |
Labcorp Genetics |
RCV002533848 | SCV003330426 | pathogenic | Developmental and epileptic encephalopathy, 1; Autosomal dominant nonsyndromic hearing loss 65; Caused by mutation in the TBC1 domain family, member 24 | 2022-08-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 620424). This variant has not been reported in the literature in individuals affected with TBC1D24-related conditions. This variant is present in population databases (rs763626059, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Glu148*) in the TBC1D24 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBC1D24 are known to be pathogenic (PMID: 23526554, 24291220). |